Who Owns 10x Genomics Stock?
NASDAQ: TXGIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 120.32%
- Institutions (% of float)
- 122.08%
- Held by insiders
- 1.44%
- Institutional holders
- 524
- Institutions 98.6%
- Insiders 1.4%
- Public and other 0.0%
Who owns 10x Genomics stock?
Institutional investors own about 120.3% of 10x Genomics's shares, spread across 524 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.44% of TXG.
The largest institutional holders are FMR, LLC (14.67%), Blackrock Inc. (8.99%) and ARK Investment Management, LLC (8.32%). Together, the top 10 institutions control 60.1% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their TXG positions and 5 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TXG
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 17.63M | 14.67% | -0.6% |
| Blackrock Inc. | 10.80M | 8.99% | +7.2% |
| ARK Investment Management, LLC | 10.00M | 8.32% | -14.6% |
| Vanguard Portfolio Management LLC | 6.98M | 5.81% | +1.0% |
| Quantinno Capital Management, LP | 5.47M | 4.55% | +1.1% |
| Vanguard Capital Management LLC | 5.08M | 4.23% | -3.5% |
| Price (T.Rowe) Associates Inc | 4.54M | 3.78% | +2681.0% |
| Sumitomo Mitsui Trust Group, Inc. | 4.19M | 3.49% | -17.9% |
| Amova Asset Management Americas Inc | 4.19M | 3.49% | -17.9% |
| Morgan Stanley | 3.35M | 2.79% | +26.2% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TXG
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.53M | 2.94% |
| iShares Trust-iShares Russell 2000 ETF | 3.06M | 2.54% |
| ARK ETF Trust-ARK Genomic Revolution ETF | 3.04M | 2.53% |
| ARK ETF Trust-ARK Innovation ETF | 3.01M | 2.50% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.55M | 2.12% |
| Fidelity Select PORT.s-Select Medical Technology and Devices PORT. | 2.00M | 1.66% |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 1.66M | 1.38% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 1.63M | 1.36% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.47M | 1.22% |
| T. Rowe Price New Horizons Fund, Inc. | 1.46M | 1.21% |
Frequently asked questions
Who is the largest shareholder of 10x Genomics?
FMR, LLC is the largest institutional shareholder of TXG, owning 14.67% of shares outstanding (17.63M shares) as of its latest 13F filing.
What percentage of 10x Genomics is owned by institutions?
Institutions own about 120.3% of TXG shares and 122.1% of the public float.
How much of 10x Genomics do insiders own?
Insiders, such as officers and directors, own about 1.44% of TXG shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.